M. Leone, L. Bouadma, and B. Bouhemad, Hospital-acquired pneumonia in ICU, Anaesth Crit Care Pain Med, vol.37, issue.1, pp.83-98, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01788072

F. S. Taccone, K. B. Laupland, and P. Montravers, Continuous infusion of ?-lactam antibiotics for all critically ill patients?, Intensive Care Med, vol.42, issue.10, pp.1604-1606, 2016.

P. S. Mc-kinnon, J. A. Paladino, and J. J. Schentag, Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predcitors of outcome for cefepime and ceftazidime in serious bacterial infections, Int J Antimicrob Agents, vol.31, issue.4, pp.345-51, 2008.

J. A. Roberts, S. K. Paul, and M. Akova, DALI: Defining Antibiotic Levels in Intensive care unit patients: are current ?-lactam antibiotic doses sufficient for critically ill patients, Clin Infect Dis, vol.58, pp.1072-83, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01954093

A. A. Udy, J. M. Varghese, and M. Altukroni, Subtherapeutic initial ?-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations, Chest, vol.142, pp.30-39, 2012.

A. Huttner, V. Dach, E. Renzoni, and A. , Augmented renal clearance, low ?-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study, Int J Antimicrob Agents, vol.45, pp.385-92, 2015.

B. O. Claus, E. A. Hoste, K. Colpaert, H. Robays, J. Decruyenaere et al., Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy, J Crit Care, vol.28, pp.695-700, 2013.

C. Carrie, M. Bentejac, and V. Cottenceau, Association between augmented renal clearance and clinical failure of antibiotic treatment in brain-injured patients with ventilator-acquired pneumonia: a preliminary study, Anaesth Crit Care Pain Med, vol.37, pp.35-41, 2018.

C. Carrie, L. Petit, and N. Houdain, Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill patients receiving high doses of ?-lactams administered by continuous infusion: a prospective observational study

, Int J Antimicrob Agents, vol.51, issue.3, pp.443-452, 2018.

C. Carrié, R. Legeron, and L. Petit, Higher than standard dosing regimen are needed to achieve optimal antibiotic exposure in critically ill patients with augmented renal 45 clearance receiving piperacillin-tazobactam administered by continuous infusion, J Crit Care, vol.48, pp.66-71, 2018.

J. Ollivier, C. Carrié, and N. Houdain, Are standard dosing regimens of ceftriaxone adapted for critically ill patients with augmented creatinine clearance? A prospective observational study, Antimicrob Agents Chemother. 2019, vol.26, issue.3

T. Besnard, C. Carrié, L. Petit, and M. Biais, Increased dosing regimens of piperacillintazobactam are needed to avoid subtherapeutic exposure in critically ill patients with augmented renal clearance, Crit Care, vol.23, issue.1, p.13, 2019.

S. Dhaese, J. A. Roberts, M. Carlier, A. G. Verstraete, V. Stove et al., Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients, Int J Antimicrob Agents, vol.51, issue.4, pp.594-600, 2018.

M. A. Babyak, What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models, Psychosom Med, vol.66, issue.3, pp.411-432, 2004.

P. C. Austin, An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies, Multivar Behav Res, vol.46, pp.399-424, 2011.

P. C. Austin, The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies, Med Decis Mak Int J Soc Med Decis Mak, vol.29, pp.661-677, 2009.

P. C. Austin and D. S. Small, The use of bootstrapping when using propensity-score matching without replacement: a simulation study, Stat Med, vol.33, pp.4306-4319, 2014.

A. Rhodes, L. E. Evans, and W. Alhazzani, Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock, Intensive Care Med, vol.43, pp.304-77, 2016.

F. B. Sime, A. A. Udy, and J. A. Roberts, Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization, Curr Opin Pharmacol, vol.24, pp.1-6, 2015.

M. Carlier, M. Noë, D. Waele, and J. J. , Population pharmacokinetics and dosing simulations of amoxicillin/clavulanic acid in critically ill patients, J Antimicrob Chemother, vol.68, issue.11, pp.2600-2608, 2013.

J. A. Roberts, M. Ulldemolins, and M. S. Roberts, Therapeutic drug monitoring of betalactams in critically ill patients: proof of concept, Int J Antimicrob Agents, vol.36, pp.332-341, 2010.

M. Carlier, S. Carrette, and J. A. Roberts, Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used? Crit Care, vol.17, p.84, 2013.

M. G. Andersen, A. Thorsted, M. Storgaard, A. N. Kristoffersson, L. E. Friberg et al., Population Pharmacokinetics of Piperacillin in Sepsis Patients: Should Alternative Dosing Strategies Be Considered?, Antimicrob Agents Chemother, vol.62, issue.5, 2018.

A. A. Udy, J. Lipman, and P. Jarrett, Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?, Crit Care, vol.19, p.28, 2015.

M. Haeseker, T. Havenith, L. Stolk, C. Neef, C. Bruggeman et al., Is the standard dose of amoxicillin-clavulanic acid sufficient?, BMC Pharmacol Toxicol, vol.15, p.38, 2014.

L. Petit, C. Carrié, Q. Hisz, N. Houdain, D. Breilh et al., Are standard doses of cefazolin adapted for methicillin-susceptible staphylococcus aureus respiratory infections in critically ill patients with augmented renal clearance?, Abstract] Annals of Intensive, vol.8, issue.1, p.13, 2018.

T. Tamatsukuri, M. Ohbayashi, and N. Kohyama, The exploration of population pharmacokinetic model for meropenem in augmented renal clearance and investigation of optimum setting of dose, J Infect Chemother, vol.24, issue.10, pp.834-840, 2018.

J. P. Baptista, A. A. Udy, and E. Sousa, A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance, Crit Care, vol.15, issue.3, p.139, 2011.

C. Carrié, S. Rubin, P. Sioniac, D. Breilh, and M. Biais, The kinetic glomerular filtration rate is not interchangeable with measured creatinine clearance for prediction of piperacillin underexposure in critically ill patients with augmented renal clearance, Crit Care, vol.22, issue.1, p.177, 2018.

J. F. Barletta, A. J. Mangram, and M. Byrne, Identifying augmented renal clearance in trauma patients: Validation of the Augmented Renal Clearance in Trauma Intensive Care scoring system, J Trauma Acute Care Surg, vol.82, issue.4, pp.665-71, 2017.

C. Carrie, A. Lannou, S. Rubin, D. Courson, H. Petit et al., Augmented renal clearance in critically ill trauma patients: A pathophysiologic approach using renal vascular index, Anaesth Crit Care Pain Med, p.47, 2018.

A. Jacobs, F. S. Taccone, J. A. Roberts, F. Jacobs, F. Cotton et al., ?-Lactam dosage regimens in septic patients with augmented renal clearance, Antimicrob Agents Chemother, vol.62, issue.9, pp.2534-2551, 2018.

T. W. Felton, J. A. Roberts, T. P. Lodise, M. Van-guilder, E. Boseli et al., Individualization of piperacillin dosing for critically ill patients: dosing software to optimize antimicrobial therapy, Antimicrob Agents Chemother, vol.58, issue.7, pp.4094-102, 2018.

M. Beumier, G. S. Casu, M. Hites, F. Wolff, F. Cotton et al., Elevated ?-lactam concentrations associated with neurological deterioration in ICU septic patients

, Minerva Anestesiol, vol.81, pp.497-506, 2015.

S. Imani, H. Buscher, D. Marriott, S. Gentili, and I. Sandaradura, Too much of a good thing: a retrospective study of ?-lactam concentration-toxicity relationships, J Antimicrob Chemother, vol.72, pp.2891-97, 2017.

Y. Launey, O. Brissaud, and R. Bruyère, Pneumonies associées aux soins de réanimation

, Anesthésie & Réanimation, vol.4, issue.5, pp.421-462, 2018.

A. C. Kalil, M. L. Metersky, and M. Klompas, Management of Adults With Hospitalacquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the, Clin Infect Dis, vol.63, issue.5, pp.61-111, 2016.

, Saint-Maurice (Fra) : Santé publique France, septembre 2019, Surveillance des infections nosocomiales en réanimation adulte, vol.80, p.p, 2017.

D. Koulenti, E. Tsigou, and J. Rello, Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study, Eur. J. Clin. Microbiol. Infect. Dis, vol.36, issue.11, pp.1999-2006, 2017.

W. Branch-elliman, S. B. Wright, and M. D. Howell, Determining the Ideal Strategy for Ventilator-associated Pneumonia Prevention. Cost-Benefit Analysis, Am J Respir Crit Care Med, vol.192, issue.1, pp.57-63, 2015.

A. Kumar, D. Roberts, and K. E. Wood, Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*, Crit Care Med, vol.34, issue.6, pp.1589-96, 2006.

F. Alvarez-lerma, Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group, Intensive Care Med, vol.22, issue.5, pp.387-94, 1996.

C. M. Luna, P. Vujacich, and M. S. Niederman, Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia, Chest, vol.111, issue.3, pp.676-85, 1997.

C. Luyt, N. Bréchot, J. Trouillet, and J. Chastre, Antibiotic stewardship in the intensive care unit, Crit Care, vol.18, issue.5, p.480, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01313131

, Optimisation du traitement par B-lactamines -RFE SFAR, 2018.

. Sitegpr,

S. Deshayes, A. Coquerel, and R. Verdon, Neurological Adverse Effects Attributable to ?-Lactam Antibiotics: A Literature Review, Drug Saf, vol.40, issue.12, pp.1171-98, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02368947

D. Tsai, J. Lipman, and J. A. Roberts, Pharmacokinetic/pharmacodynamic considerations for the optimization of antimicrobial delivery in the critically ill, Curr Opin Crit Care, vol.21, issue.5, pp.412-432, 2015.

I. K. Delattre, F. S. Taccone, and F. Jacobs, Optimizing ?-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?, Expert Rev Anti Infect Ther, vol.15, issue.7, pp.677-88, 2017.

J. A. Roberts, S. K. Paul, and M. Akova, DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients, Clin Infect Dis, vol.58, issue.8, pp.1072-83, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01954093

E. Boselli, D. Breilh, and T. Rimmelé, Alveolar concentrations of piperacillin/tazobactam administered in continuous infusion to patients with ventilator-associated pneumonia, Crit Care Med, vol.36, issue.5, pp.1500-1506, 2008.

S. K. Olofsson, P. Geli, D. I. Andersson, and O. Cars, Pharmacodynamic model to describe the concentration-dependent selection of cefotaxime-resistant Escherichia coli

, Antimicrob Agents Chemother, vol.49, issue.12, pp.5081-91, 2005.

C. Gianvecchio, N. A. Lozano, and C. Henderson, Variation in Mutant Prevention Concentrations, Front Microbiol, vol.10, p.42, 2019.

M. Ulldemolins, J. A. Roberts, J. Rello, D. L. Paterson, and J. Lipman, The Effects of Hypoalbuminaemia on Optimizing Antibacterial Dosing in Critically Ill Patients, Clin Pharmacokinet, vol.50, issue.2, pp.99-110, 2011.

M. Ulldemolins, I. Martín-loeches, and M. Llauradó-serra, Piperacillin population pharmacokinetics in critically ill patients with multiple organ dysfunction syndrome receiving continuous venovenous haemodiafiltration: effect of type of dialysis membrane on dosing requirements, J Antimicrob Chemother, vol.71, issue.6, pp.1651-1660, 2016.

S. G. Sakka, A. K. Glauner, and J. B. Bulitta, Population Pharmacokinetics and Pharmacodynamics of Continuous versus Short-Term Infusion of Imipenem-Cilastatin in Critically Ill Patients in a Randomized, Controlled Trial, Antimicrob Agents Chemother, vol.51, issue.9, pp.3304-3314, 2007.

L. Lorente, A. Jiménez, M. M. Martín, J. L. Iribarren, J. J. Jiménez et al., Clinical cure of ventilator-associated pneumonia treated with piperacillin/tazobactam administered by continuous or intermittent infusion, Int J Antimicrob Agents, vol.33, issue.5, pp.464-472, 2009.

F. Scaglione, S. Esposito, and S. Leone, Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia, Eur Respir J, vol.34, issue.2, pp.394-400, 2009.

A. E. Muller, B. Huttner, and A. Huttner, Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections?, Drugs, vol.78, issue.4, pp.439-51, 2018.

J. J. De-waele, A. Dumoulin, A. Janssen, and E. A. Hoste, Epidemiology of augmented renal clearance in mixed ICU patients, Minerva Anestesiol, vol.81, issue.10, pp.1079-85, 2015.

H. Barrasa and I. Bilbao-meseguer, Augmented Renal Clearance in Critically Ill Patients : A Systematic Review, 2018.

A. A. Udy, J. M. Dulhunty, and J. A. Roberts, Association between augmented renal clearance and clinical outcomes in patients receiving ?-lactam antibiotic therapy by continuous or intermittent infusion: a nested cohort study of the BLING-II randomised, placebo-controlled, clinical trial, Int J Antimicrob Agents, vol.49, issue.5, pp.624-654, 2017.

C. C. May, S. Arora, S. E. Parli, J. F. Fraser, M. T. Bastin et al., Augmented Renal Clearance in Patients with Subarachnoid Hemorrhage, Neurocrit Care, vol.23, issue.3, pp.374-383, 2015.

B. Claus, E. A. Hoste, K. Colpaert, H. Robays, J. Decruyenaere et al., Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy, J Crit Care, vol.28, issue.5, pp.695-700, 2013.

R. Palsson and S. S. Waikar, Renal Functional Reserve Revisited, Adv Chronic Kidney Dis, vol.25, issue.3, pp.1-8, 2018.

A. A. Udy, P. Jarrett, and M. Lassig-smith, Augmented Renal Clearance in Traumatic Brain Injury: A Single-Center Observational Study of Atrial Natriuretic Peptide, Cardiac Output, and Creatinine Clearance, J Neurotrauma, vol.34, issue.1, pp.137-181, 2017.

A. A. Udy, J. A. Roberts, R. J. Boots, D. L. Paterson, and J. Lipman, Augmented Renal Clearance, Clin Pharmacokinet, vol.49, issue.1, pp.1-16, 2010.

M. Carlier, A. Dumoulin, and A. Janssen, Comparison of different equations to assess glomerular filtration in critically ill patients, Intensive Care Med, vol.41, issue.3, pp.427-462, 2015.

J. Baptista, A. A. Udy, and E. Sousa, A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance, Crit Care, vol.15, issue.3, p.139, 2011.

S. Adnan, S. Ratnam, and S. Kumar, Select critically ill patients at risk of augmented renal clearance: experience in a Malaysian intensive care unit, Anaesth Intensive Care, vol.42, issue.6, pp.715-737, 2014.

J. F. Barletta, A. J. Mangram, and M. Byrne, Identifying augmented renal clearance in trauma patients: Validation of the Augmented Renal Clearance in Trauma Intensive Care scoring system, J Trauma Acute Care Surg, vol.82, issue.4, pp.665-71, 2017.

A. Huttner, V. Dach, E. Renzoni, and A. , Augmented renal clearance, low ?-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study, Int J Antimicrob Agents, vol.45, issue.4, pp.385-92, 2015.

M. Carlier, S. Carrette, and J. A. Roberts, Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used?, Crit Care, vol.17, issue.3, p.84, 2013.

C. Carrié, L. Petit, D. 'houdain, and N. , Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of ?-lactams administered by continuous infusion: a prospective observational study, Int J Antimicrob Agents, vol.51, issue.3, pp.443-452, 2018.

A. A. Udy, J. M. Varghese, and M. Altukroni, Subtherapeutic Initial ?-Lactam Concentrations in Select Critically Ill Patients, Chest, vol.142, issue.1, pp.30-39, 2012.

C. Carrie, M. Bentejac, and V. Cottenceau, Association between augmented renal clearance and clinical failure of antibiotic treatment in brain-injured patients with ventilator-acquired pneumonia: A preliminary study, Anaesth Crit Care Pain Med, vol.37, issue.1, pp.35-41, 2018.

A. A. Udy, J. Lipman, and P. Jarrett, Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance, Crit Care, vol.19, issue.1, p.28, 2015.

C. Carrié, R. Legeron, and L. Petit, Higher than standard dosing regimen are needed to achieve optimal antibiotic exposure in critically ill patients with augmented renal clearance receiving piperacillin-tazobactam administered by continuous infusion, J Crit Care, vol.48, pp.66-71, 2018.

P. Longuet, A. L. Lecapitaine, and B. Cassard, Preparing and administering injectable antibiotics: How to avoid playing God, Médecine Mal Infect, vol.46, issue.5, pp.242-68, 2016.

S. Dhaese, J. A. Roberts, M. Carlier, A. G. Verstraete, V. Stove et al., Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients, Int J Antimicrob Agents, vol.51, issue.4, pp.594-600, 2018.

T. Besnard, C. Carrié, L. Petit, and M. Biais, Increased dosing regimens of piperacillintazobactam are needed to avoid subtherapeutic exposure in critically ill patients with 66 augmented renal clearance, Crit Care, vol.23, issue.1, p.13, 2019.

J. Ollivier, C. Carrié, D. 'houdain, and N. , Are Standard Dosing Regimens of Ceftriaxone Adapted for Critically Ill Patients with Augmented Creatinine Clearance?, Antimicrob Agents Chemother, vol.63, issue.3, 2019.

M. Carlier, M. Noe, D. Waele, and J. J. , Population pharmacokinetics and dosing simulations of amoxicillin/clavulanic acid in critically ill patients, J Antimicrob Chemother, vol.68, issue.11, pp.2600-2608, 2013.

T. Tamatsukuri, M. Ohbayashi, and N. Kohyama, The exploration of population pharmacokinetic model for meropenem in augmented renal clearance and investigation of optimum setting of dose, J Infect Chemother, vol.24, issue.10, pp.834-874, 2018.

P. G. Cojutti, C. Barbarino, A. De-monte, W. Hope, and F. Pea, Higher than standard meropenem and linezolid dosages needed for appropriate treatment of an intracerebral hemorrhage patient with augmented renal clearance, Eur J Clin Pharmacol, vol.74, issue.8, pp.1091-1093, 2018.

Y. Yamashita, H. Kamiyama, and A. Yamamoto, Relationship between PK/PD of Cefepime and Clinical Outcome in Febrile Neutropenic Patients with Normal Renal Function, YAKUGAKU ZASSHI, vol.136, issue.12, pp.1641-1650, 2016.

A. Jacobs, F. S. Taccone, and J. A. Roberts, ?-Lactam Dosage Regimens in Septic Patients with Augmented Renal Clearance, Antimicrob Agents Chemother, vol.62, issue.9, 2018.

A. Rhodes, L. E. Evans, and W. Alhazzani, Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016, Crit Care Med, vol.45, issue.3, pp.486-552, 2017.

W. G. Melsen, M. M. Rovers, and R. Groenwold, Attributable mortality of ventilatorassociated pneumonia: a meta-analysis of individual patient data from randomised prevention studies, Lancet Infect Dis, vol.13, issue.8, pp.665-71, 2013.

J. A. Roberts, M. Ulldemolins, and M. S. Roberts, Therapeutic drug monitoring of betalactams in critically ill patients: proof of concept, Int J Antimicrob Agents, vol.36, issue.4, pp.332-341, 2010.

E. Angles, C. Mouton, J. Perino, A. Remy, and A. Ouattara, Hypoprothrombinemia and severe perioperative haemorrhagic complications in cardiac surgery patients treated with high-dose cefazolin for infective endocarditis, Anaesth Crit Care Pain Med, vol.37, issue.2, pp.167-70, 2018.

. Serment-d'hippocrate,

, Au moment d'être admis(e) à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux, individuels et sociaux

, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions

, J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences

, Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire

, Reçu(e) à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs

, Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément

, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses